Consensus Forte Biosciences, Inc.

Equities

FBRX

US34962G1094

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
0.6962 USD +0.19% Intraday chart for Forte Biosciences, Inc. +0.90% -15.27%

Evolution of the average Target Price on Forte Biosciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

8c1fc3a3304920e741b40dbc9531fa3.Hs3CEKklPPaYKDc9-2WP8e1Aw5Qqv6jj1Pr0X_Vnwh4.df2PVJgTRZHMT1l2qQrEpZQY9s5PjfyFk86HM7kstEpqr5R95RRdg-tGWA~878ff20faa758b3c14012e43dee47576

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6962 USD
Average target price
3 USD
Spread / Average Target
+330.91%
High Price Target
3 USD
Spread / Highest target
+330.91%
Low Price Target
3 USD
Spread / Lowest Target
+330.91%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Forte Biosciences, Inc.

Chardan
Brookline Capital Management
Ladenburg Thalmann
Truist Securities
B. Riley
Citigroup
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Quarterly revenue - Rate of surprise